Document is current
Any future updates will be listed below
-
Authors
Guan, Yingyun
Li, Xiaoye
Li, Hui
Ren, Jinmei
Tang, Kouming
Zhang, Chi
Gu, Zhichun
Li, Xiaoyu
Lv, Qianzhou
Bian, Xiaolan https://orcid.org/0009-0001-1151-9057
-
Funding
Funding for this research was provided by:
Shanghai Pharmaceutical Society (SHYXHZP-2021-002)
- License Information
-
More Information
Article History
Received: 22 August 2023
Accepted: 17 October 2023
First Online: 18 November 2023
Declarations
:
: This study involving human participants was reviewed and approved by the Research Ethics Commission of Ruijin Hospital (KY 2022–154). The Research Ethics Committee approved the study protocol and waived the informed consent because of the retrospective nature of this study.
: This work was supported by Clinical comprehensive evaluation and treatment management pathway of sav/val in the real world of hypertension. Grant/Award Number: SHYXHZP-2021-002.
: The authors have no relevant financial or non-financial interests to disclose.
: All authors contributed to the study conception and design. Data collection and analysis were performed by YG, XL, JR, CZ, ZG. The first draft of the manuscript was written by YG and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
